Buy $AMGN - NRPicks 19 Nov

업데이트됨
Amgen Inc. discovers, develops, manufactures and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience areas. It has agreements with Novartis, Bayer, among others.

Revenue TTM 25.7B
Net Income TTM 5.6B
EBITDA TTM 12.1B
EBITDA margin TTM 47.1%.
Debt/EBITDA TTM 3.05x
거래청산: 타겟 닿음
Dec 16
Chart PatternsFundamental Analysishealthcarestockideas

또한 다음에서도:

면책사항